← All organizations

Ontario Institute for Cancer Research

Academic/HospitalWebsite ↗

Also known as: OICR | Ontario Institute for Cancer Research

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 1, 2024

Timeline

2000s

Jan 1, 2005
Ontario Institute for Cancer Research— Founded

Drugs by trial phase (22 distinct, 16 trials)

Phase 3 (1 own, 0 via acquisition)

Inactivated Mycobacterium obuense

Phase 2 (16 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Other trials (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (16)

NCT06191250CollaboratorPhase 2Oct 1, 2024
NCT05967884CollaboratorPhase 2Aug 4, 2023
NCT05332483CollaboratorPhase 1Jul 5, 2022
NCT05380713CollaboratorPhase 2May 9, 2022
NCT04781725CollaboratorPhase 2Mar 25, 2021
NCT04676516CollaboratorPhase 2Dec 21, 2020
NCT04469556CollaboratorPhase 2Oct 14, 2020
NCT04543110CollaboratorPhase 2Sep 30, 2020
NCT04442048CollaboratorPhase 3Jun 25, 2020
NCT04221165CollaboratorPhase 2Feb 1, 2020
NCT02921373CollaboratorPhase 1Jul 31, 2019
NCT03568422CollaboratorPhase 1/Phase 2Sep 30, 2018
NCT03129776CollaboratorPhase 1Jul 1, 2017
NCT02793284CollaboratorN/AJan 9, 2017
NCT02121600CollaboratorN/ASep 30, 2014

Details

Founded: Toronto, CA Jan 1, 2005
Last known activity: Oct 1, 2024